75 related articles for article (PubMed ID: 29216855)
1. Timeliness of Care and Lung Cancer Tumor-Stage Progression: How Long Can We Wait?
Maiga AW; Deppen SA; Pinkerman R; Callaway-Lane C; Massion PP; Dittus RS; Lambright ES; Nesbitt JC; Baker D; Grogan EL
Ann Thorac Surg; 2017 Dec; 104(6):1791-1797. PubMed ID: 29033012
[TBL] [Abstract][Full Text] [Related]
2. Barriers to Timely Lung Cancer Care in Early Stage Non-Small Cell Lung Cancer and Impact on Patient Outcomes.
Pirzadeh M; Lagina M; Wood C; Valley T; Ramnath N; Arenberg D; Deng JC
Clin Lung Cancer; 2024 Mar; 25(2):135-143. PubMed ID: 37981476
[TBL] [Abstract][Full Text] [Related]
3. Strengths and challenges in current lung cancer care: Timeliness and diagnostic procedures in six Dutch hospitals.
Genet SAAM; Visser E; Youssef-El Soud M; Belderbos HNA; Stege G; de Saegher MEA; Westeinde SCV'; Brunsveld L; Broeren MAC; van de Kerkhof D; Eduati F; van den Borne BEEM; Scharnhorst V
Lung Cancer; 2024 Mar; 189():107477. PubMed ID: 38271919
[TBL] [Abstract][Full Text] [Related]
4. The bottleneck effect in lung cancer clinical trials.
Gonzalez LE; Sutton SK; Pratt C; Gilbertson M; Antonia S; Quinn GP
J Cancer Educ; 2013 Sep; 28(3):488-93. PubMed ID: 23733149
[TBL] [Abstract][Full Text] [Related]
5. Wait Times Experienced by Lung Cancer Patients in the BC Southern Interior to Obtain Oncologic Care: Exploration of the Intervals from First Abnormal Imaging to Oncologic Treatment.
Van de Vosse D; Chowdhury R; Boyce A; Halperin R
Cureus; 2015 Sep; 7(9):e330. PubMed ID: 26543688
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey.
Kızılırmak D; Yılmaz Kaya Z; Gökçimen G; Havlucu Y; Cengiz Özyurt B; Gündoğuş B; Esendağlı D; Serez Kaya B; Yılmam İ; Aydemir Y; Çolak M; Afşin E; Çetin N; İdikut A; Değirmenci C; Oral Tapan Ö; Gündüz Gürkan C; Kocatürk Cİ; Ömeroğlu Şimşek G; Kalafat CE; Özgün Niksarlıoğlu EY; Ergün Serdaroğlu M; Karcıoğlu O; Özyurt S; Karahacıoğlu Madran E; Yaprak Bayrak B; Alasgarova Z; Baydar Toprak O; Yılmazel Uçar E; Topal BN; Argun Barış S; Guliyev E; Güzel E; Küçük S; Ocaklı B; Baran Ketencioğlu B; Selçuk NT; Sarı Akyüz M; Sercan Özgür E; Yetkin NA; Çetinkaya PD; Deniz PP; Atlı S; Çetindoğan H; Karakaş FG; Yılmaz ES; Ergün D; Ergün R; Tulay CM; Ünsal M; Demirkaya İ; Marım F; Kaya İ; Demirdöğen E; Görek Dilektaşlı A; Ursavaş A; Çelik P
Cancer Epidemiol; 2023 Dec; 87():102480. PubMed ID: 37897971
[TBL] [Abstract][Full Text] [Related]
7. Proactive consultation of laboratory medicine increased diagnostic rate of multiple myeloma: One single center's 12-year experience.
Chang CC; Ho JL; Lin PC; Lin CP; Tsai WT; Huang HL; Yu YB; Chen WC; Chu FY
Medicine (Baltimore); 2024 Jun; 103(23):e38523. PubMed ID: 38847713
[TBL] [Abstract][Full Text] [Related]
8. Implementation and outcomes of the RAPID programme: Addressing the front end of the lung cancer pathway in Manchester.
Evison M; Hewitt K; Lyons J; Crosbie P; Balata H; Gee C; Duerden R; Greaves M; Sharman A; Booton R
Clin Med (Lond); 2020 Jul; 20(4):401-405. PubMed ID: 32675147
[TBL] [Abstract][Full Text] [Related]
9. [The role of the pulmonologist in the therapeutic strategy for stage I bronchopulmonary cancers?].
Gounant V; Khalil A; Zalcman G
Rev Mal Respir; 2024 Mar; 41(3):172-174. PubMed ID: 38514242
[No Abstract] [Full Text] [Related]
10. Incidental pulmonary nodule management in Canada: exploring current state through a narrative literature review and expert interviews.
Digby GC; Habert J; Sahota J; Zhu L; Manos D
J Thorac Dis; 2024 Feb; 16(2):1537-1551. PubMed ID: 38505054
[TBL] [Abstract][Full Text] [Related]
11. Plasma-derived exosomal immunoglobulins IGHV4-4 and IGLV1-40 as new non-small cell lung cancer biomarkers.
Yang P; Zhang Y; Zhang R; Wang Y; Zhu S; Peng X; Zeng Y; Yang B; Pan M; Gong J; Ba H
Am J Cancer Res; 2023; 13(5):1923-1937. PubMed ID: 37293178
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of
Xie F; Zheng K; Liu L; Jin X; Fu L; Zhu Z
Front Oncol; 2022; 12():877501. PubMed ID: 35720018
[TBL] [Abstract][Full Text] [Related]
13. Defining timeliness in care for patients with lung cancer: a scoping review.
Ansar A; Lewis V; McDonald CF; Liu C; Rahman MA
BMJ Open; 2022 Apr; 12(4):e056895. PubMed ID: 35393318
[TBL] [Abstract][Full Text] [Related]
14. Interventions to improve early cancer diagnosis of symptomatic individuals: a scoping review.
Okoli GN; Lam OLT; Reddy VK; Copstein L; Askin N; Prashad A; Stiff J; Khare SR; Leonard R; Zarin W; Tricco AC; Abou-Setta AM
BMJ Open; 2021 Nov; 11(11):e055488. PubMed ID: 34753768
[TBL] [Abstract][Full Text] [Related]
15. An Audit of CT Chest Reports and Their Potential Impact on the Workup of Patients with Suspected Lung Cancer.
Weinstock A; Jeagal L; Savard C; Taylor J; Gonzalez AV
Can Respir J; 2021; 2021():6647087. PubMed ID: 34194587
[TBL] [Abstract][Full Text] [Related]
16. Lung Cancer Pre-Diagnostic Pathways from First Presentation to Specialist Referral.
Khare SR; Madathil SA; Batist G; Peter Brojde Lung Cancer Group ; Vedel I
Curr Oncol; 2021 Jan; 28(1):378-389. PubMed ID: 33440696
[TBL] [Abstract][Full Text] [Related]
17. Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung Cancer: Findings From the PLCO Trial.
Abdel-Rahman O
World J Surg; 2019 Nov; 43(11):2927-2933. PubMed ID: 31332492
[TBL] [Abstract][Full Text] [Related]
18. Predicting delays in lung cancer diagnosis and staging.
Leiro-Fernández V; Mouronte-Roibás C; García-Rodríguez E; Botana-Rial M; Ramos-Hernández C; Torres-Durán M; Ruano-Raviña A; Fernández-Villar A;
Thorac Cancer; 2019 Feb; 10(2):296-303. PubMed ID: 30605236
[TBL] [Abstract][Full Text] [Related]
19. Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment.
Ezer N; Navasakulpong A; Schwartzman K; Ofiara L; Gonzalez AV
BMC Pulm Med; 2017 Dec; 17(1):178. PubMed ID: 29216855
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
